Supawat Thongthip
Stock Analyst at Truist Financial
(0.26)
# 4,565
Out of 5,060 analysts
16
Total ratings
20%
Success rate
-22.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Supawat Thongthip
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Reiterated: Buy | $26 | $16.51 | +57.48% | 3 | Oct 15, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $18 | $16.66 | +8.04% | 2 | Oct 6, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $40 | $22.12 | +80.83% | 5 | Sep 8, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $10.94 | +357.04% | 3 | Aug 13, 2026 | |
| IMNM Immunome | Reiterated: Buy | $38 | $16.47 | +130.72% | 3 | Aug 12, 2026 |
Janux Therapeutics
Oct 15, 2026
Reiterated: Buy
Price Target: $26
Current: $16.51
Upside: +57.48%
ArriVent BioPharma
Oct 6, 2026
Reiterated: Buy
Price Target: $18
Current: $16.66
Upside: +8.04%
Arcus Biosciences
Sep 8, 2026
Reiterated: Buy
Price Target: $40
Current: $22.12
Upside: +80.83%
Sutro Biopharma
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $10.94
Upside: +357.04%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $38
Current: $16.47
Upside: +130.72%